News
CSTAR is part of the successful consortium that has been awarded funding of €6 million by the European Commission for clinical trials for a new Alzheimer's disease treatment. Please see NILVAD clinical trials press release for further details.
CSTAR is part of the successful consortium that has been awarded funding of €6 million by the European Commission for clinical trials for a new Alzheimer's disease treatment. Please see NILVAD clinical trials press release for further details.